Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets

Annals of Nutrition and Metabolism

Volumn 54, Issue 2, 2009, Pages 104-110

  De Luis, D A ^a   Gonzalez Sagrado M ^a   Aller, R ^a   Izaola, O ^a   Conde, R ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipocytokines; Beta 3 adrenoreceptor; Diet, hypocaloric; Obesity; Trp64Arg

Indexed keywords

ADIPOCYTOKINE; ARGININE; BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; LEPTIN; TRIACYLGLYCEROL; TRYPTOPHAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; METABOLISM; MUTANT; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; WILD TYPE;

ADIPOKINES; ANTHROPOMETRY; CALORIMETRY, INDIRECT; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; DIET, REDUCING; FEMALE; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; MUTATION; OBESITY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA-3; RESISTIN; WEIGHT LOSS;

EID: 62349103697     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209268     Document Type: Article

References (30)

1. Kopelman PG: Obesity as a medical problem. Nature 2000;404:635-643.
2. Rosenbaum M, Leibel RL, Hirsch J: Medical prog ress: obesity. N Engl J Med 1997;337: 396-407.
3. Thomas GN, Tomlinson B, Chang JCN, Young RP, Critchley JAJH: The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 2000;25:545-551.
4. Bracale R, Pasanisi F, Labruna G, Finelli C, Nardelli C, Buono P, Salvatori G, Sacchetti L, Contaldo F, Oriani G: Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy. Eur J Clin Nutr 2007;61:1213-1219.
5. Matsuda M, Shimomura I, Sata M: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-37491.
6. Kumada M, Kihara S, Sumitsuji S: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89.
7. Shimomoura I, Hammer RE, Ikemoto S: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76.
8. Steppan CM, Bailey ST, Bhat S: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
9. Knowler WC, Barret-Connor E, Fowler SE: Diabetes Prevention Program Research Group. Reduction in incidence of type 2 diabetes with lifestyle intervention or metfor-min. N Engl J Med 2002;346:393-403.
10. Urhammer SA, Clausen JO, Hansen T, Pedersen O: Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3adrenergic receptor gene. Diabetes 1996;45: 1115-1120.
11. Shiwaku K, Nogi A, Anuurad E, Kitajima K, Enkhmaa B, Shimono K, Yamane Y: Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta 3-adrenergic receptor gene. Int J Obes Relat Metab Disor 2003;27:1028-1036.
12. Rawson ES, Nolan A, Silver K, Shuldiner AR, Poehlman ET: No effect of the Trp64Arg beta (3)-adrenoreceptor gene variant on weight loss, body composition, or energy expenditure in obese, Caucasian postmenopausal women. Metabolism 2002;51:801-805.
13. Sorensen TI, Boutin P, Taylor M A, Larsen LH, Verdich C, Petersen L, Holst C, Echwald SM, Dina C, Toubro S, Petersen M, Polak J, Clément K, Martínez JA, Langin D, Oppert JM, Stich V, Macdonald I, Arner P, Saris WH, Pedersen O, Astrup A, Froguel P: Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high versus low-fat diets. PLoS Clin Trials 2006;1: e12.
14. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF: Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
15. Feurer ID, Mullen JL: Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract 1986;1:43-49.
16. Lukaski H, Johson PE: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810-817.
17. Mataix J, Mañas M: Tablas de Composición de Alimentos Españoles. Granada, University of Granada, 1998.
18. Yoshida T, Sakane N, Umekawa T, Sakai Y, Takahashi T, Kondo M: Mutation of beta 3-adrenoreceptor gene and response to treatment of obesity. Lancet 1995;346: 1433-1444.
19. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M: Effects of Trp64Arg mutation in the beta 3-adrenoreceptor gene on weight loss, body fat distribution, glyce-mic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997;20:1887-1992.
20. de Luis DA, Aller R, Izaola O, Gonzalez Sa-grado M, Conde R: Influence of the Trp64Arg polymorphism in the beta 3-adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients. Eur J Intern Med 2007; 18:587-592.
21. Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Filer JS: Targeted disruption of the beta 3 adrener-gic receptor gene. Endocrinology 1995;270: 29483-29492.
22. Hoffstedt J, Wahrenberg H, Thome A, Lönn-qvist F: The metabolic syndrome is related to beta 3-adrenoreceptor sensitivity in visceral adipose tissue. Diabetologia 1996;39:838-844.
23. Vendrell J, Gutierrez C, Broch M, Fernandez Real JM, Agilar C, Richart C: Beta 3-adreno-receptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients. Clin Endocrinol 1998;49:679-683.
24. Baron AD, Brechtel-Hook G, Johnson A, Cronin J: Effect of perfusion rate on the time course of insulin mediated skeletal muscle glucose uptake. Am J Physiol 1996;271: 1067-1072.
25. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogi-hara T, Tuck ML: Beta 2 adrenoreceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normo-tensive individuals. Am J Hypertens 2005;18:1009-1014.
26. Hojlund K, Christiansen C, Bjornsbo KS, Poulsen P, Bathum L, Henriksen JE, Lam-mert O, Beck-Nielsen H: Energy expenditure, body composition and insulin response to glucose in male twins discordant for the Trp64Arg polymorphism of the beta3-ad-renergic receptor gene. Diabetes Obes Metab 2006;8:322-330.
27. de Luis DA, Aller R, Izaola O, Gonzalez Sa-grado M, Conde R: Relation of Trp64Arg polymorphism of beta 3-adrenergic receptor gene to adipocytokines and fat distribution in obese patients. Ann Nutr Metab 2008;52: 267-271.
28. Kadowaki H, Yasuda K, Iwamoto K: A mutation in the beta 3 adrenoreceptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995;215:555-560.
29. Xinli W, Xiaomei T, Meihua P, Song L: Association of a mutation in the beta 3 adren-ergic receptor gene with obesity and response to dietary intervention in Chinese children. Acta Paediatr 2001;90:1233-1237.
30. Tsai SJ, Yu YW, Lin CH, Wang YC, Chen JY, Hong CJ: Association study of adrenergic beta3 receptor (Trp64Arg) and G protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment. Neuropsychobiology 2004;50:37-40.